FR2788780B1 - Procede de preparation de vesicules membranaires - Google Patents

Procede de preparation de vesicules membranaires

Info

Publication number
FR2788780B1
FR2788780B1 FR9900886A FR9900886A FR2788780B1 FR 2788780 B1 FR2788780 B1 FR 2788780B1 FR 9900886 A FR9900886 A FR 9900886A FR 9900886 A FR9900886 A FR 9900886A FR 2788780 B1 FR2788780 B1 FR 2788780B1
Authority
FR
France
Prior art keywords
preparation
membrane vesicles
vesicles
membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9900886A
Other languages
English (en)
Other versions
FR2788780A1 (fr
Inventor
Olivier Dhellin
Sebastian Amigorena
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AP Cells Inc
Original Assignee
AP Cells Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9900886A priority Critical patent/FR2788780B1/fr
Application filed by AP Cells Inc filed Critical AP Cells Inc
Priority to CA002360752A priority patent/CA2360752A1/fr
Priority to EP00900609A priority patent/EP1143982A2/fr
Priority to JP2000595691A priority patent/JP2002535665A/ja
Priority to CN00802903A priority patent/CN1355704A/zh
Priority to PCT/FR2000/000105 priority patent/WO2000044389A2/fr
Priority to EA200100819A priority patent/EA003235B1/ru
Priority to AU30561/00A priority patent/AU768322B2/en
Priority to US09/890,319 priority patent/US6899863B1/en
Priority to IL14369200A priority patent/IL143692A0/xx
Publication of FR2788780A1 publication Critical patent/FR2788780A1/fr
Application granted granted Critical
Publication of FR2788780B1 publication Critical patent/FR2788780B1/fr
Priority to HK02102905.8A priority patent/HK1042647A1/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34—Size selective separation, e.g. size exclusion chromatography, gel filtration, permeation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • B01J41/20—Anion exchangers for chromatographic processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR9900886A 1999-01-27 1999-01-27 Procede de preparation de vesicules membranaires Expired - Fee Related FR2788780B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR9900886A FR2788780B1 (fr) 1999-01-27 1999-01-27 Procede de preparation de vesicules membranaires
US09/890,319 US6899863B1 (en) 1999-01-27 2000-01-19 Method for preparing membrane vesicles
JP2000595691A JP2002535665A (ja) 1999-01-27 2000-01-19 膜小胞を調製するための方法
CN00802903A CN1355704A (zh) 1999-01-27 2000-01-19 膜囊泡的制法
PCT/FR2000/000105 WO2000044389A2 (fr) 1999-01-27 2000-01-19 Procede de preparation de vesicules membranaires
EA200100819A EA003235B1 (ru) 1999-01-27 2000-01-19 Способ получения мембранных пузырьков
CA002360752A CA2360752A1 (fr) 1999-01-27 2000-01-19 Procede de preparation de vesicules membranaires
EP00900609A EP1143982A2 (fr) 1999-01-27 2000-01-19 Procede de preparation de vesicules membranaires
IL14369200A IL143692A0 (en) 1999-01-27 2000-01-19 Methods for preparing membrane vesicles
AU30561/00A AU768322B2 (en) 1999-01-27 2000-01-19 Method for preparing membrane vesicles
HK02102905.8A HK1042647A1 (zh) 1999-01-27 2002-04-17 製備膜囊的方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9900886A FR2788780B1 (fr) 1999-01-27 1999-01-27 Procede de preparation de vesicules membranaires

Publications (2)

Publication Number Publication Date
FR2788780A1 FR2788780A1 (fr) 2000-07-28
FR2788780B1 true FR2788780B1 (fr) 2001-03-30

Family

ID=9541269

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9900886A Expired - Fee Related FR2788780B1 (fr) 1999-01-27 1999-01-27 Procede de preparation de vesicules membranaires

Country Status (11)

Country Link
US (1) US6899863B1 (fr)
EP (1) EP1143982A2 (fr)
JP (1) JP2002535665A (fr)
CN (1) CN1355704A (fr)
AU (1) AU768322B2 (fr)
CA (1) CA2360752A1 (fr)
EA (1) EA003235B1 (fr)
FR (1) FR2788780B1 (fr)
HK (1) HK1042647A1 (fr)
IL (1) IL143692A0 (fr)
WO (1) WO2000044389A2 (fr)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003016522A2 (fr) 2001-08-17 2003-02-27 Anosys, Inc. Procedes et composes pour le ciblage de proteines vers des exosomes
CA2609260A1 (fr) * 2004-06-02 2005-12-22 Sourcepharm, Inc. Microvesicules contenant de l'arn et methodes associees
US8021847B2 (en) 2004-06-02 2011-09-20 Proxy Life Science Holdings, Inc. Microvesicle-based compositions and methods
US8758991B2 (en) * 2006-04-26 2014-06-24 University Of Louisville Research Foundation, Inc. Isolation of membrane vesicles from biological fluids and methods of using same
JP2010516786A (ja) * 2007-01-26 2010-05-20 ユニバーシティー オブ ルイヴィル リサーチ ファウンデーション，インコーポレーテッド ワクチンとしての使用のためのエキソソーム成分の改変
CA2733672C (fr) 2007-08-16 2018-09-11 The Royal Institution For The Advancement Of Learning/Mcgill University Microvesicules issues d'une cellule tumorale
US20100255514A1 (en) * 2007-08-16 2010-10-07 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
EP3708682B1 (fr) * 2008-02-01 2022-11-23 The General Hospital Corporation Utilisation de microvésicules dans le diagnostic et le pronostic de maladies et d'état de santé
US20220162704A1 (en) * 2008-02-01 2022-05-26 The General Hospital Corporation Methods of preparing microvesicle micrornas from bodily fluids
US11266736B2 (en) 2008-04-17 2022-03-08 Vin De Bona Trading Company Pte Ltd Method of painting micro vesicles
WO2014057128A2 (fr) 2012-10-11 2014-04-17 Vin-De-Bona Trading Company Pte Ltd Procédé de peinture de microvésicules
BRPI0919882A8 (pt) 2008-10-30 2017-09-19 Caris Life Sciences Luxembourg Holdings Métodos para avaliar padrões de rna
CN102301002A (zh) 2008-11-12 2011-12-28 卡里斯生命科学卢森堡控股有限责任公司 使用外来体来确定表现型的方法和***
CN102498397B (zh) 2009-07-16 2016-04-06 总医院有限公司 核酸分析
EP2475988B1 (fr) 2009-09-09 2018-11-14 The General Hospital Corporation Utilisation de microvésicules dans l'analyse de profils d'acide nucléique
EP3865590B1 (fr) 2009-09-09 2024-04-10 The General Hospital Corporation Utilisation de microvésicules dans l'analyse de mutations kras
JP5892939B2 (ja) 2009-11-02 2016-03-23 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 細胞状態をモニタリングするための方法及び間葉系幹細胞を不死化するための方法
AU2010324594B2 (en) 2009-11-30 2016-09-15 Caris Life Sciences Switzerland Holdings Gmbh Methods and systems for isolating, storing, and analyzing vesicles
US20120315324A1 (en) 2010-02-05 2012-12-13 University Of Louisville Research Foundation, Inc. Exosomal compositions and methods for the treatment of disease
JP5808349B2 (ja) 2010-03-01 2015-11-10 カリス ライフ サイエンシズ スウィッツァーランド ホールディングスゲーエムベーハー セラノーシスのためのバイオマーカー
US9469876B2 (en) 2010-04-06 2016-10-18 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers for metastatic prostate cancer
EP2591359B1 (fr) 2010-07-07 2017-03-01 Aethlon Medical Inc Procédés permettant de quantifier des exosomes
US20140045915A1 (en) 2010-08-31 2014-02-13 The General Hospital Corporation Cancer-related biological materials in microvesicles
EP2638057B1 (fr) 2010-11-10 2019-03-06 Exosome Diagnostics, Inc. Procédés d'isolement de particules contenant des acides nucléiques et extraction d'acides nucléiques à partir de celles-ci
US20140004601A1 (en) * 2010-12-20 2014-01-02 Agency For Science, Technology And Research Method of purifying exosomes
US20140212871A1 (en) 2011-05-11 2014-07-31 Exosome Diagnostics, Inc. Nucleic Acid Extraction from Heterogeneous Biological Materials
EP2723865B1 (fr) 2011-06-21 2019-03-27 Alnylam Pharmaceuticals, Inc. PROCÉDÉS DE DÉTERMINATION DE L'ACTIVITÉ DU RNAi CHEZ UN SUJET
GB201110777D0 (en) * 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
GB201110783D0 (en) 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
ES2395793B1 (es) * 2011-07-28 2013-12-27 Consejo Superior De Investigaciones Científicas (Csic) Procedimiento de obtención y usos de vesículas de membrana de un organismo marino para su utilización industrial.
EP3492606B1 (fr) 2011-08-22 2023-10-04 Exosome Diagnostics, Inc. Biomarqueurs urinaires
WO2013071239A1 (fr) 2011-11-10 2013-05-16 Exosome Diagnostics, Inc. Dosage du liquide céphalorachidien
ES2967272T3 (es) 2011-11-30 2024-04-29 Bullerdiek Joern Expresión de miARNs en tejido placentario
CN103479682B (zh) * 2012-06-14 2015-03-11 苏州恒宇生物科技有限公司 一种植物来源活性成分-纳米级膜性囊泡的制备方法
EP3299814A3 (fr) * 2012-07-19 2018-04-11 Atlantic Cancer Research Institute Procédé d'isolement de microvésicules
CA2879322A1 (fr) * 2012-07-19 2014-01-23 Reneuron Limited Microparticules de cellules souches
CA2882248A1 (fr) 2012-08-15 2014-02-20 The University Of Chicago Produits therapeutiques a base d'exosome contre des troubles neurodegeneratifs
CA2883220C (fr) 2012-08-30 2022-09-20 Exosome Diagnostics, Inc. Temoins pour dosages d'acide nucleique
US20150252428A1 (en) 2012-10-03 2015-09-10 Exosome Diagnostics, Inc. Use of microvesicles in diagnosis, prognosis, and treatment of medical diseases and conditions
US10942184B2 (en) 2012-10-23 2021-03-09 Caris Science, Inc. Aptamers and uses thereof
JP6449781B2 (ja) 2013-01-03 2019-01-09 エクソサム ダイアグノスティクス，インコーポレイティド 微細小胞の単離方法
EP2971282B1 (fr) 2013-03-14 2018-09-19 Pioma Inc. Histone h2ax microvésiculaire en tant que biomarqueur pour le stress génotoxique
EP3335721A1 (fr) * 2013-04-12 2018-06-20 Evox Therapeutics Limited Vésicules d'administration thérapeutique
RU2668164C2 (ru) 2013-08-06 2018-09-26 Эксосам Дайэгностикс, Инк. Когорты биомаркеров мочи, профиль экспрессии генов и способы их применения
GB201317887D0 (en) 2013-10-09 2013-11-20 Reneuron Ltd Product
CN105980615A (zh) 2013-08-28 2016-09-28 卡里斯生命科学瑞士控股有限公司 寡核苷酸探针及其用途
EP3052616A4 (fr) * 2013-10-02 2017-03-29 Paradigm Biopharmaceuticals Limited Procédé de production d'exosomes
CN105658782B (zh) 2013-10-25 2018-08-07 凸版印刷株式会社 膜囊泡回收设备、膜囊泡回收方法及膜囊泡分析方法
FR3014198B1 (fr) * 2013-12-03 2017-03-03 Biomerieux Sa Procede d'isolement d'exosomes
JP6343671B2 (ja) * 2013-12-12 2018-06-13 サムスン ライフ パブリック ウェルフェア ファウンデーション トロンビンを利用した幹細胞由来のエキソソームの生成促進方法
JP6295341B2 (ja) 2014-03-18 2018-03-14 サムソン ライフ パブリック ウェルフェア ファウンデーション 幹細胞由来エキソソームを有効成分として含む脳炎症性疾患の治療用組成物
EP3125907A4 (fr) 2014-04-01 2017-11-29 Cornell University Utilisation d'adn double brin dans des exosomes : un nouveau biomarqueur dans la détection du cancer
US11268085B2 (en) 2014-05-27 2022-03-08 Exosome Diagnostics, Inc. Methods for isolating microvesicles and extracting nucleic acids from biological samples
JP6759182B2 (ja) 2014-07-09 2020-09-23 エクソサム ダイアグノスティクス，インコーポレイティド 微小小胞体を単離する方法、および生体試料から核酸を抽出する方法
EP3169691B1 (fr) 2014-07-17 2020-09-02 The Trustees Of The University Of Pennsylvania Procédés permettant d'utiliser des exosomes pour surveiller l'état d'un organe transplanté
SG11201700557RA (en) 2014-07-24 2017-02-27 Toppan Printing Co Ltd Lipid membrane structure, lipid-membrane-structure-immobilization carrier, and method for fusing cells
EP3112474A1 (fr) 2015-06-29 2017-01-04 Evonik Degussa GmbH Procédé de détection d'entérite nécrotique aviaire
CA2979361A1 (fr) 2015-03-09 2016-09-15 Caris Science, Inc. Methode de preparation de bibliotheques d'oligonucleotides
EP4218780A1 (fr) * 2015-06-12 2023-08-02 Hudson Institute of Medical Research Exosomes allogènes amniotiques pour le traitement de maladies
EP3314027A4 (fr) 2015-06-29 2019-07-03 Caris Science, Inc. Oligonucléotides thérapeutiques
US10941176B2 (en) 2015-07-28 2021-03-09 Caris Science, Inc. Therapeutic oligonucleotides
EP3165926A1 (fr) 2015-11-06 2017-05-10 Humanitas Mirasole S.p.A. Procédé de caractérisation des microvésicules spécifiques de cellule
CN106811428A (zh) * 2015-11-30 2017-06-09 复旦大学 一种提取细菌外排膜囊泡的方法
RU2608509C1 (ru) * 2016-02-11 2017-01-18 Елена Сергеевна Кастарнова Способ получения экзосом из крови
IL260988B2 (en) 2016-03-03 2023-03-01 Roussy Inst Gustave ptps-based vaccines against cancer
US11702702B2 (en) 2016-04-15 2023-07-18 Predicine, Inc. Systems and methods for detecting genetic alterations
WO2018057820A1 (fr) 2016-09-21 2018-03-29 Predicine, Inc. Systèmes et procédés de détection combinée d'altérations génétiques
CN109563547A (zh) 2016-04-15 2019-04-02 外来体诊断公司 间变性淋巴瘤激酶(alk)核酸和alk融合转录物的基于血浆的检测及其在癌症诊断和治疗中的用途
WO2017192945A1 (fr) 2016-05-05 2017-11-09 Exosome Diagnostics, Inc. Profilage d'acides nucléiques de microvésicules et leurs utilisations en tant que signatures en diagnostic de rejet de greffe de rein
AU2017263886B2 (en) 2016-05-13 2023-11-09 Exosome Diagnostics, Inc. Automated and manual methods for isolation of extracellular vesicles and co-isolation of cell-free DNA from biofluids
CN109153882B (zh) 2016-05-24 2022-03-04 公益财团法人癌研究会 细胞外小泡回收方法及细胞外小泡用容器
US11299733B2 (en) 2016-07-15 2022-04-12 University Of Massachusetts Process of delivering small RNAs to sperm
IL247368A0 (en) 2016-08-18 2016-11-30 Yeda Res & Dev Diagnostic and therapeutic uses of exosomes
US11396676B2 (en) 2016-10-21 2022-07-26 Exosome Diagnostics, Inc. Sequencing and analysis of exosome associated nucleic acids
AU2017366813B2 (en) 2016-11-30 2023-04-20 Exosome Diagnostics, Inc. Methods and compositions to detect mutations in plasma using exosomal RNA and cell free DNA from non-small cell lung cancer patients
KR20190100174A (ko) 2016-12-23 2019-08-28 엑소팜 리미티드 미세소포 및 엑소좀의 정제 또는 단리를 위한 방법 및 조성물
EP3562959A2 (fr) 2017-01-02 2019-11-06 Exosome Diagnostics, Inc. Procédés de distinction d'arn et d'adn dans une préparation combinée
KR101875594B1 (ko) * 2017-01-13 2018-07-06 ㈜로제타엑소좀 금속을 이용한 세포밖 소포체의 분리 방법
DK3622082T3 (da) 2017-05-12 2023-06-12 Evonik Operations Gmbh Fremgangsmåde til påvisning af c. perfringens-inducerede sygdomme i en fugleflok
JP7225121B2 (ja) 2017-05-17 2023-02-20 エクソサム ダイアグノスティクス，インコーポレイティド 微小胞核酸および／またはタンパク質、並びに腎移植拒絶反応マーカーとしてのその使用
CN111133106A (zh) 2017-07-12 2020-05-08 外来体诊断公司 用于分离和富集生物流体来源的细胞外囊泡的方法及其使用方法
US11345957B2 (en) 2017-07-18 2022-05-31 Exosome Diagnostics, Inc. Methods of treating glioblastoma in a subject informed by exosomal RNA signatures
EP3660142A4 (fr) * 2017-07-26 2021-05-05 Rosetta Exosome Procédé d'isolement de vésicules extracellulaires à l'aide de cations
TR201716062A2 (tr) * 2017-10-18 2019-05-21 Tuerkiye Bilimsel Ve Teknolojik Arastirma Kurumu Tuebitak Bi̇r eksozomal terapöti̇k taşiyici üreti̇m yöntemi̇ ve bu yönteme uygun bi̇r şeki̇lde elde edi̇len bi̇r eksozomal terapöti̇k taşiyici
GB201717446D0 (en) 2017-10-24 2017-12-06 Evox Therapeutics Ltd Affinity purification of engineering extracellular vesicles
MX2020004507A (es) 2017-11-09 2020-08-13 Alnylam Pharmaceuticals Inc Ensayos y métodos para determinar la expresión del gen de quimiotaxina 2 derivada de leucocitos (lect2).
WO2019104169A1 (fr) * 2017-11-21 2019-05-31 Purina Animal Nutrition Llc Procédés de purification d'exosomes
WO2019160519A2 (fr) 2018-02-15 2019-08-22 Yeditepe Universitesi Procédé d'isolement d'exosomes par un système de fluide à deux phases
CN111770931B (zh) * 2018-02-20 2023-08-25 高丽大学校产学协力团 用于分离外泌体的多柱及外泌体分离方法
US20210230701A1 (en) 2018-06-06 2021-07-29 Exosome Diagnostics, Inc. Methods for developing urine biomarkers and for detecting bladder cancer
GB201809622D0 (en) 2018-06-12 2018-07-25 Evox Therapeutics Ltd Engineering extracellular vesicles for affinity purification
CN108841777A (zh) * 2018-06-22 2018-11-20 北京恩泽康泰生物科技有限公司 基于静电吸附的胞外囊泡及其内含物的提取方法及装置
CN112805562A (zh) * 2018-07-31 2021-05-14 国立大学法人三重大学 外泌体的制造方法
WO2020106853A1 (fr) 2018-11-20 2020-05-28 Exosome Diagnostics, Inc. Compositions et procédés de témoins internes d'isolements de microvésicules
IT201800021226A1 (it) * 2018-12-27 2020-06-27 Supsi Scuola Univ Professionale Della Svizzera Italiana Processo e dispositivo per produrre esosomi
CN109856259A (zh) * 2018-12-29 2019-06-07 南通大学附属医院 一种血清胰腺癌外泌体特异蛋白及其再验证过程
KR102212465B1 (ko) * 2019-01-16 2021-02-03 서울시립대학교 산학협력단 알엔에이 나노입자 전달을 통한 소포체의 제조방법 및 이로부터 제조된 소포체
CN109825472A (zh) * 2019-03-01 2019-05-31 易春 一种细胞外囊泡的提取方法及试剂盒
EP4135746A1 (fr) 2020-04-13 2023-02-22 Exoprother Medical Ltd. Vésicules dérivées de cellules comprenant une protéine p53 de type sauvage pour une thérapie antivirale
US20210322483A1 (en) 2020-04-16 2021-10-21 Ichilov Tech Ltd. Cell-derived particles presenting heterologous cd24 and use thereof in therapy
GB202010278D0 (en) 2020-07-03 2020-08-19 Evox Therapeutics Ltd Extracellular vesicles with improved half-life
IL277743A (en) 2020-10-01 2022-04-01 Yeda Res & Dev A method for diagnosing breast cancer
KR20220097337A (ko) * 2020-12-30 2022-07-07 한국과학기술원 엑소좀 분리용 조성물 및 이를 이용한 엑소좀 분리 방법
GB202105925D0 (en) 2021-04-26 2021-06-09 Evox Therapeutics Ltd Modified extracellular vesicles (EVs) with improved half-life
JP2023104650A (ja) * 2022-01-18 2023-07-28 ダイセン・メンブレン・システムズ株式会社 細胞外小胞の分離精製方法
WO2024024336A1 (fr) * 2022-07-28 2024-02-01 株式会社ダイセル Dispositif de purification et de concentration d'un liquide comprenant une substance utile infime et procédé de production d'un liquide purifié et concentré d'une substance utile infime l'utilisant
CN117070450B (zh) * 2023-10-12 2024-01-16 哈药集团生物工程有限公司 一种外泌体的纯化方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989000846A1 (fr) * 1987-07-29 1989-02-09 The Liposome Company, Inc. Procede de separation granulometrique de particules
US20030198642A1 (en) * 1995-08-03 2003-10-23 Johannes J. Geuze Cell derived antigen presenting vesicles
US6165785A (en) * 1996-05-24 2000-12-26 University Of Cincinnati Bone marrow cultures for developing suppressor and stimulator cells for research and therapeutic applications
WO1997045900A1 (fr) * 1996-05-31 1997-12-04 The Whitaker Corporation Connecteur de batterie rechargeable
FR2766205B1 (fr) * 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede

Also Published As

Publication number Publication date
EA003235B1 (ru) 2003-02-27
JP2002535665A (ja) 2002-10-22
EA200100819A1 (ru) 2001-12-24
HK1042647A1 (zh) 2002-08-23
CN1355704A (zh) 2002-06-26
FR2788780A1 (fr) 2000-07-28
WO2000044389A2 (fr) 2000-08-03
CA2360752A1 (fr) 2000-08-03
AU3056100A (en) 2000-08-18
AU768322B2 (en) 2003-12-11
WO2000044389A3 (fr) 2000-11-16
US6899863B1 (en) 2005-05-31
IL143692A0 (en) 2002-04-21
EP1143982A2 (fr) 2001-10-17

Similar Documents

Publication Publication Date Title
FR2788780B1 (fr) Procede de preparation de vesicules membranaires
FI20010154A (fi) Menetelmä citalopramin valmistamiseksi
FR2818977B1 (fr) Procede de preparation du citalopram pur
FR2813077B1 (fr) Procede de preparation du citalopram
MA25223A1 (fr) Procede pour la preparation de 4-carboxy-amino-2-substitue-1,2,3,4 tetrahydroquinoleine
IS5982A (is) Aðferð til framleiðslu á 5-sýanóþalíði
FR2781801B1 (fr) Procede pour la preparation de dianhydride pyromellique
FR2782093B1 (fr) Procede de preparation de cultures de bacteries lactiques
FR2818979B1 (fr) Procede de preparation d'imidaclopride
FR2728895B1 (fr) Procede de preparation du difluoromethane
FR2814460B1 (fr) Procede de preparation de granules frittes de titanate de lithium
NO20024956L (no) Fremgangsmåte for fremstilling av ionebyttemembraner
FR2826002B1 (fr) Procede de preparation de composes bromodifluoroacetiques
FR2768725B1 (fr) Procede de preparation du 2-chloroprop-1-ene
FR2806085B1 (fr) Procede de preparation du citalopram
FR2791669B1 (fr) Procede de preparation du fluoroformiate de tertiobutyle
MA24464A1 (fr) Procede de preparation de composes nouveaux .
FR2840296B1 (fr) Procede de preparation d'une membrane zeolithique de faible epaisseur
FR2805535B1 (fr) Nouveau procede de preparation de l'isoindoline
FR2750998B1 (fr) Procede de preparation de k-carraghenase
FR2763942B1 (fr) Nouveau procede de preparation de n-acylaminoacides
FR2722131B1 (fr) Procede de preparation de melanges aqueux agrileux pompables
FR2802924B1 (fr) Procede de preparation des 6-halogeno-2-chloroquinoxalines
FR2728566B1 (fr) Procede de preparation de pentene-nitriles
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse

Effective date: 20060929